Pandemic Prompts Update To Belgian Rules On HCP Participation In Scientific Events
Pharmaceutical and medtech companies operating in Belgium now have a clearer idea of the rules governing the participation of health care professionals in scientific events.
You may also be interested in...
New EU guidance will cover non-clinical and clinical development, trial design, endpoints, safety issues and comparators, as well as the use of immunobridging studies.
The new committee, which will initially be in place for a year, will advise the French drug regulator when it is preparing its opinions on substitution in specific biosimilar product groups.
The TGA has taken a series of actions to address supply chain issues, including on the regulatory front, but it says more remains to be done and is asking stakeholders for suggestions in a new online survey.